- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 445
Artemis Health arcs to $25m series C
Hearst Health Ventures contributed to a BVP-led round that boosted the health benefits data platform's total funding to about $51m.
Mar 18, 2019Corporate venturing deal net: 11-15 March 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 15, 2019Gencove adds $3m to funding sequence
New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.
Mar 15, 2019Yunhu delivers series A-plus
The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.
Mar 15, 2019TriNetX triumphs in $40m series D
The healthcare research platform has increased its total funding to $102m following a Merck GHI-led round that included Itochu Technology Ventures and Mitsui.
Mar 15, 2019Aldrich administers $41m to eHealth
The medical record retrieval software provider, which received funding from Merck & Co in 2013, has secured $41m from Aldrich Capital Partners.
Mar 15, 2019Well Doc recuperates with $1.6m
Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.
Mar 14, 2019Docquity rocks $11m series B round
The physician-based social media platform has raised $11m in a round co-led by Itochu, which supplied $6m, and existing backer Singapore Press Holdings.
Mar 14, 2019Verano to reap $850m in Harvest acquisition
Scythian Biosciences-backed cannabis facilities operator Verano has agreed to an $850m acquisition by Harvest Health and Recreation in an all-stock transaction.
Mar 13, 2019InventisBio invites Eli Lilly to $70m series C
Lilly Asia Ventures has returned for a series C round that boosted the total raised by the cancer and metabolic disease drug developer to $100m.
Mar 13, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


